These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 30228853)
1. Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency. Feldo M; Woźniak M; Wójciak-Kosior M; Sowa I; Kot-Waśik A; Aszyk J; Bogucki J; Zubilewicz T; Bogucka-Kocka A Oxid Med Cell Longev; 2018; 2018():2561705. PubMed ID: 30228853 [TBL] [Abstract][Full Text] [Related]
2. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids. Jantet G Angiology; 2002; 53(3):245-56. PubMed ID: 12025911 [TBL] [Abstract][Full Text] [Related]
3. [Possibilities of pharmacotherapy for chronic venous insufficiency with diosmin preparations from the position of the endothelial functional state]. Kalinin RE; Suchkov IA; Pshennikov AS; Mzhavanadze ND Angiol Sosud Khir; 2015; 21(3):91-4, 96-7. PubMed ID: 26355927 [TBL] [Abstract][Full Text] [Related]
5. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Lyseng-Williamson KA; Perry CM Drugs; 2003; 63(1):71-100. PubMed ID: 12487623 [TBL] [Abstract][Full Text] [Related]
6. From symptoms to leg edema: efficacy of Daflon 500 mg. Nicolaides AN Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755 [TBL] [Abstract][Full Text] [Related]
7. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Struckmann JR; Nicolaides AN Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. Bergan JJ; Schmid-Schönbein GW; Takase S Angiology; 2001 Aug; 52 Suppl 1():S43-7. PubMed ID: 11510596 [TBL] [Abstract][Full Text] [Related]
9. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids. Jantet G Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641 [TBL] [Abstract][Full Text] [Related]
10. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency. Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889 [TBL] [Abstract][Full Text] [Related]
11. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Cospite M; Dominici A Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903 [TBL] [Abstract][Full Text] [Related]
12. Antioxidant Potential of Diosmin and Diosmetin against Oxidative Stress in Endothelial Cells. Wójciak M; Feldo M; Borowski G; Kubrak T; Płachno BJ; Sowa I Molecules; 2022 Nov; 27(23):. PubMed ID: 36500323 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of micronized purified flavonoid fraction: an overview. Struckmann JR J Vasc Res; 1999; 36 Suppl 1():37-41. PubMed ID: 10474049 [TBL] [Abstract][Full Text] [Related]
14. Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction - a pilot study. Shoab SS; Scurr JH; Coleridge-Smith PD Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):334-8. PubMed ID: 10550269 [TBL] [Abstract][Full Text] [Related]
15. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study. Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M Angiology; 2005; 56(1):1-8. PubMed ID: 15678250 [TBL] [Abstract][Full Text] [Related]
16. A plasma oxidative stress global index in early stages of chronic venous insufficiency. Condezo-Hoyos L; Rubio M; Arribas SM; España-Caparrós G; Rodríguez-Rodríguez P; Mujica-Pacheco E; González MC J Vasc Surg; 2013 Jan; 57(1):205-13. PubMed ID: 23182154 [TBL] [Abstract][Full Text] [Related]
17. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M Angiology; 2006; 57(2):131-8. PubMed ID: 16518519 [TBL] [Abstract][Full Text] [Related]
18. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)]. Iablokov EG; Bogachev VIu; Domoradskaia AI Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder]. Hnátek L Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280 [TBL] [Abstract][Full Text] [Related]
20. Synthetic Diosmin in the therapy of venous diseases. Signorelli S; Ferrara M; Tornetta D; Interlandi S; Amico-Roxas MT; Monaco S; Andreozzi GM Panminerva Med; 1987; 29(2):165-7. PubMed ID: 3627817 [No Abstract] [Full Text] [Related] [Next] [New Search]